Log In
person
Ionis Pharmaceuticals Inc
IONS
summarize
3 total product lines
calendar_month
Revenue as of 12/31/2023
| Reporting Segmentarrow_drop_up | Product Line | Amount (USD) | Percentage |
|---|---|---|---|
| keyboard_arrow_right | Reporting Segment & Product Line | Amount (USD) | Percentage |
| RNA Targeted Therapeutics |
Pre-Revenue Pharmaceuticals
These companies research and develop pharmaceuticals, but do not generate significant revenue. They may eventually market or manufacture their products (pending regulatory approval) or generate revenue through royalties or other means.
|
479.06M | 60.82% |
| RNA Targeted Therapeutics |
Pharmaceutical Patent Licensing
These companies collect royalties from pharma and biotech companies who make biotech products they developed or products that incorporate their technologies.
|
240.38M | 30.52% |
| RNA Targeted Therapeutics |
Branded Pharmaceuticals
These companies research, develop, and manufacture patented drugs.
|
68.21M | 8.66% |
| keyboard_arrow_down |
RNA Targeted Therapeutics
Pre-Revenue Pharmaceuticals
|
479.06M | 60.82% |
| keyboard_arrow_right |
These companies research and develop pharmaceuticals, but do not generate significant revenue. They may eventually market or manufacture their products (pending regulatory approval) or generate revenue through royalties or other means.
|
||
| keyboard_arrow_down |
RNA Targeted Therapeutics
Pharmaceutical Patent Licensing
|
240.38M | 30.52% |
| keyboard_arrow_right |
These companies collect royalties from pharma and biotech companies who make biotech products they developed or products that incorporate their technologies.
|
||
| keyboard_arrow_down |
RNA Targeted Therapeutics
Branded Pharmaceuticals
|
68.21M | 8.66% |
| keyboard_arrow_right |
These companies research, develop, and manufacture patented drugs.
|
||